146 related articles for article (PubMed ID: 37800675)
1. Clinical outcomes of oral epithelial dysplasia managed by observation versus excision.
Bernard C; Zhang JZ; Klieb H; Blanas N; Xu W; Magalhaes M
Head Neck; 2023 Dec; 45(12):3096-3106. PubMed ID: 37800675
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading.
Dost F; Lê Cao K; Ford PJ; Ades C; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):343-52. PubMed ID: 24388536
[TBL] [Abstract][Full Text] [Related]
3. The clinical determinants of malignant transformation in oral epithelial dysplasia.
Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
[TBL] [Abstract][Full Text] [Related]
4. Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
Sarode GS; Sarode SC; Sengupta N; Sharma NK; Patil S
Oral Oncol; 2021 Jun; 117():105181. PubMed ID: 33500183
[TBL] [Abstract][Full Text] [Related]
5. Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
Ellis BG; Whitley CA; Triantafyllou A; Gunning PJ; Smith CI; Barrett SD; Gardner P; Shaw RJ; Weightman P; Risk JM
PLoS One; 2022; 17(3):e0266043. PubMed ID: 35333891
[TBL] [Abstract][Full Text] [Related]
6. Loss of FANCD2 and related proteins may predict malignant transformation in oral epithelial dysplasia.
Ho MW; Ryan MP; Gupta J; Triantafyllou A; Risk JM; Shaw RJ; Wilson JB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Apr; 133(4):377-387. PubMed ID: 34493474
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
Mahmood H; Shephard A; Hankinson P; Bradburn M; Araujo ALD; Santos-Silva AR; Lopes MA; Vargas PA; McCombe KD; Craig SG; James J; Brooks J; Nankivell P; Mehanna H; Rajpoot N; Khurram SA
Br J Cancer; 2023 Nov; 129(10):1599-1607. PubMed ID: 37758836
[TBL] [Abstract][Full Text] [Related]
9. Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit.
Gilvetti C; Soneji C; Bisase B; Barrett AW
Oral Oncol; 2021 Oct; 121():105462. PubMed ID: 34303087
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
[TBL] [Abstract][Full Text] [Related]
11. Identification of specific clinical risk factors associated with the malignant transformation of oral epithelial dysplasia.
Kierce J; Shi Y; Klieb H; Blanas N; Xu W; Magalhaes M
Head Neck; 2021 Nov; 43(11):3552-3561. PubMed ID: 34472151
[TBL] [Abstract][Full Text] [Related]
12. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.
Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R
J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839
[TBL] [Abstract][Full Text] [Related]
13. A digital score of peri-epithelial lymphocytic activity predicts malignant transformation in oral epithelial dysplasia.
Bashir RMS; Shephard AJ; Mahmood H; Azarmehr N; Raza SEA; Khurram SA; Rajpoot NM
J Pathol; 2023 Aug; 260(4):431-442. PubMed ID: 37294162
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of oral leukoplakia: a follow-up study.
Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
[TBL] [Abstract][Full Text] [Related]
15. Is there any benefit in surgery for potentially malignant disorders of the oral cavity?
Balasundaram I; Payne KF; Al-Hadad I; Alibhai M; Thomas S; Bhandari R
J Oral Pathol Med; 2014 Apr; 43(4):239-44. PubMed ID: 23750566
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters.
Wang YP; Chen IC; Wu YH; Wu YC; Chen HM; Yu-Fong Chang J
J Formos Med Assoc; 2017 Jun; 116(6):457-463. PubMed ID: 28292622
[TBL] [Abstract][Full Text] [Related]
19. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
20. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
